- Home
- MRUS vs AL Comparison
MRUS vs AL Comparison
Compare MRUS & AL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- AL
- Stock Information
- Founded
- MRUS 2003
- AL 2010
- Country
- MRUS Netherlands
- AL United States
- Employees
- MRUS N/A
- AL N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- AL Diversified Commercial Services
- Sector
- MRUS Health Care
- AL Consumer Discretionary
- Exchange
- MRUS Nasdaq
- AL Nasdaq
- Market Cap
- MRUS 4.1B
- AL 4.7B
- IPO Year
- MRUS 2016
- AL 2011
- Fundamental
- Price
- MRUS $67.47
- AL $63.71
- Analyst Decision
- MRUS Strong Buy
- AL Buy
- Analyst Count
- MRUS 13
- AL 5
- Target Price
- MRUS $90.92
- AL $61.40
- AVG Volume (30 Days)
- MRUS 550.9K
- AL 1.9M
- Earning Date
- MRUS 10-30-2025
- AL 08-04-2025
- Dividend Yield
- MRUS N/A
- AL 1.38%
- EPS Growth
- MRUS N/A
- AL 76.97
- EPS
- MRUS N/A
- AL 8.24
- Revenue
- MRUS $56,228,000.00
- AL $2,873,037,000.00
- Revenue This Year
- MRUS $57.42
- AL $12.27
- Revenue Next Year
- MRUS $0.23
- AL $6.29
- P/E Ratio
- MRUS N/A
- AL $7.73
- Revenue Growth
- MRUS 59.77
- AL 6.15
- 52 Week Low
- MRUS $33.19
- AL $38.25
- 52 Week High
- MRUS $69.20
- AL $64.30
- Technical
- Relative Strength Index (RSI)
- MRUS 58.81
- AL 72.26
- Support Level
- MRUS $62.80
- AL $63.56
- Resistance Level
- MRUS $67.84
- AL $64.30
- Average True Range (ATR)
- MRUS 2.39
- AL 0.87
- MACD
- MRUS -0.22
- AL 0.54
- Stochastic Oscillator
- MRUS 73.67
- AL 91.91
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About AL Air Lease Corporation
Air Lease Corp is an aircraft leasing company based in the United States. It is engaged in purchasing commercial jet aircrafts directly from aircraft manufacturers and leasing those aircraft to airlines throughout the world to generate attractive returns on equity. The company also sells aircraft from its fleet to third parties, including other leasing companies, financial services companies, airlines, and other investors, and offers fleet management services to investors and owners of aircraft portfolios for a management fee. Geographically, it derives a majority of its revenue from the Asia-Pacific region and the rest from Europe, Middle East and Africa, Central America, South America, Mexico, the United States, and Canada.